Solubility and Dissolution Enhancement of Atorvastatin Calcium using Phospholipid Solid Dispersion Technique
DOI:
https://doi.org/10.31351/vol32issSuppl.pp244-253Abstract
Atorvastatin (ATR) is a poorly water-soluble anti-hyperlipidemic drug. The drug belongs to the class II group according to the biopharmaceutical classification system (BCS) with low bioavailability due to its low solubility. Solid dispersion is an effective technique for enhancing the solubility and dissolution of drugs. Phospholipid solid dispersion (PSD) using phosphatidylcholine (PC) as a carrier with or without adsorbent (magnesium aluminum silicate, silicon dioxide 15nm, silicon dioxide 30nm, calcium silicate) was used to prepare ATR PSD using different drug: PC: adsorbent ratios by solvent evaporation method. The resulted PSD was evaluated for its percentage yield, drug content, solubility, dissolution rate, Fourier transformation infrared spectroscopy (FTIR), powder X-ray diffraction study (PXRD), and differential scanning calorimetry (DSC). The prepared (PSD) showed improvement in drug solubility in all prepared formulas. The best result was obtained with F5 (ATR: PC: MAS 1:3:4). The solubility was increased by 21 folds compared to the pure drug with enhanced dissolution and decrease crystallinity.
References
References
Boyd BJ, Bergström CAS, Vinarov Z, Kuentz M, Brouwers J, Augustijns P, et al. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. European Journal of Pharmaceutical Sciences. 2019; 137:104967.
Kumar S, Bhargava D, Thakkar A, Arora S. Drug carrier systems for solubility enhancement of BCS class II drugs: A critical review. Critical Reviews in Therapeutic Drug Carrier Systems. 2013;30(3):217–56.
Azemawah V, Movahed MR, Centuori P, Penaflor R, Riel PL, Situ S, et al. State of the art comprehensive review of individual statins, their differences, pharmacology, and clinical implications. Cardiovasc Drugs Ther. 2019;33(5):625–39.
Moffat A, Osselton M, Widdop B. Clarke,s analysis of drug and poisons. 4th ed. London: The Pharmaceutical Press; 2011: p 930.
Rodde MS, Divase GT, Devkar TB, Tekade AR. Solubility and bioavailability enhancement of poorly aqueous soluble atorvastatin: In vitro, ex vivo, and in vivo studies. BioMed Research International. 2014;2014.
Ali AH, Abd-Alhammid SN. Enhancement of solubility and improvement of dissolution rate of atorvastatin calcium prepared as nanosuspension. Iraqi Journal of Pharmaceutical Sciences. 2019;28(2):46–57.
Hadi BM, Al-Khedairy EBH. Preparation and Characterization of Atorvastatin Calcium Trihydrate -cyclodextrin Inclusion Complex. International Journal of Drug Delivery Technology. 2022;12(3):1171–9.
British Pharmacopoeia Commission. British Pharmacopoeia 2016: volume III. London: TSO; 2016.
Khaleel NY, Abdulrasool AA, Ghareeb MM, Hussain SA. Solubility and dissolution improvement of ketoprofen by solid dispersion in polymer and surfactant using solvent evaporation method. International Journal of Pharmacy and Pharmaceutical Sciences. 2011;3(4):431–5.
Van Hoogevest P. Review – An update on the use of oral phospholipid excipients. European Journal of Pharmaceutical Sciences. 2017; 108:1–12.
Jo K, Cho JM, Lee H, Kim EK, Kim HC, Kim H, et al. Enhancement of aqueous solubility and dissolution of celecoxib through phosphatidylcholine-based dispersion systems solidified with adsorbent carriers. Pharmaceutics. 2019;11(1):1–14.
Yeo S, An J, Park C, Kim D, Lee J. Design and characterization of phosphatidylcholine-based solid dispersions of aprepitant for enhanced solubility and dissolution. Pharmaceutics. 2020;12(5).
Zhang Z, Chen Y, Deng J, Jia X, Zhou J, Lv H. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO 2: Preparation, characterization and in vivo studies. International Journal of Pharmaceutics. 2014;465(1–2):306–16.
Rowe R C, Sheskey P J and Quinn M E. Handbook of pharmaceutical excipients. eighth edition, London, Chicago, 2017. p 156-157.
Abdul-Rahman MM, Jawad FJ. Enhancement of aqueous solubility and dissolution rate of etoricoxib by solid dispersion technique. Iraqi Journal of Pharmaceutical Sciences. 2020;29(1):76–87.
Hussain HAM, Al-Khedairy EBH. Preparation and in vitro evaluation of cyclodextrin based effervescent and dispersible granules of carbamazepine. International Journal of Applied Pharmaceutics. 2018;10(6):290–7.
Tripathi D, Sharma K, Sahoo J, Chaudhary N. Tripathi D et al. A recent advancement in approaches used for estimation of drug solubility: A review. Der Pharmacia Lettre. 2020;12(4):15–29.
The United State Pharmacopeia (USP) 41, NF36. Convention Inc. Rockville, MD. 2018.
Muselík J, Komersová A, Kubová K, Matzick K, Skalická B. A critical overview of FDA and EMA statistical methods to compare in vitro drug dissolution profiles of pharmaceutical products. Pharmaceutics. 2021;13(10).
Ismail MY, M. Ghareeb M. Enhancement of the solubility and dissolution rate of rebamipide by using solid dispersion technique (Part I). Iraqi Journal of Pharmaceutical Sciences. 2018;27(2):55–65.
Jacobsen AC, Ejskjær L, Brandl M, Holm R, Bauer-Brandl A. Do phospholipids boost or attenuate drug absorption? In vitro and in vivo evaluation of mono- and diacyl phospholipid-based solid dispersions of celecoxib. Journal of Pharmaceutical Sciences. 2021;110(1):198–207.
Abduljabbar HH, Abd Alhammid SN. Enhancement of the solubility and the dissolution rate of tamoxifen citrate solid dispersion using Soluplus by solvent evaporation technique. Asian J Pharm Clin Res. 2019;12(1):216.
Choudhari Y, Hoefer H, Libanati C, Monsuur F, McCarthy W. Mesoporous silica drug delivery systems. 2014;665–93.
Telange DR, Sohail NK, Hemke AT, Kharkar PS, Pethe AM. Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of mangiferin. Drug Delivery and Translational Research. 2021;11(3):1056–83.
Jagtap RS, Doijad RC, Mohite SK. Adsorption of nifedipine on porous calcium silicate for enhancement of solubility and dissolution rate. Research Journal of Pharmacy and Technology. 2019;12(3):1273–9.
Ali SK, Al-Khedairy EBH. Solubility and dissolution enhancement of atorvastatin calcium using solid dispersion adsorbate technique. Iraqi Journal of Pharmaceutical Sciences. 2019;28(2):105–14.
Totea AM, Dorin I, Laity PR, Sabin J, Conway BR, Waters L, et al. A molecular understanding of magnesium aluminum silicate – drug, drug–polymer, magnesium aluminum silicate – polymer nanocomposite complex interactions in modulating drug release: Towards zero order release. European Journal of Pharmaceutics and Biopharmaceutics. 2020; 154:270–82.
Yoshie K, Yada S, Ando S, Ishihara K. Chemical structural effects of amphipathic and water-soluble phospholipid polymers on formulation of solid dispersions. Journal of Pharmaceutical Sciences. 2021;110(8):2966–73.
Ahmed A, Ali SA, Hassan F, Ayub S, Haque N. Effect of disintegrants and hardness on the disintegration time of Acetaminophen tablets. Pakistan journal of pharmaceutical sciences. 1998;11(1):41–6.
Chen X, Partheniadis I, Nikolakakis I, Al-Obaidi H. Solubility improvement of progesterone from solid dispersions prepared by solvent evaporation and co-milling. Polymers (Basel). 2020;12(4).
Fong SYK, Martins SM, Brandl M, Bauer-Brandl A. Solid phospholipid dispersions for oral delivery of poorly soluble drugs: Investigation into celecoxib incorporation and solubility in-vitro permeability enhancement. Journal of Pharmaceutical Sciences. 2016;105(3):1113–23.
Alshehri S, Imam SS, Hussain A, Altamimi MA, Alruwaili NK, Alotaibi F, et al. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents. Drug Delivery. 2020;27(1):1625–43.
Sonje VM, Kumar L, Meena CL, Kohli G, Puri V, Jain R, et al. Atorvastatin calcium. Al-Majed AA. Profiles of Drug Substances, Excipients and Related Methodology. Elsevier Inc.; 2010. 1–70 p.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
